Caracterización de la patología dermatológica presente en la población pediátrica infectada con el virus de inmunodeficiencia humana del Hospital Militar Central atendida durante el año 2006
Palabras clave:
Virus inmunodeficiencia humana, VIH, manifestaciones cutáneasResumen
La infección por el virus de inmunodeficiencia humana,VIH, ha tenido una dramática repercusión en la salud infantil, debido al aumento de mujeres infectadas en edad fértil, su posible muerte temprana y la posibilidad si han tenido hijos, de que estos niños estén huérfanos antes de los quince años de edad. Teniendo en cuenta que las manifestaciones de piel son comunes en el 80% a 95% de los pacientes pediátricos VIH positivos en cualquier curso de la infección, que por lo menos el 60% de los pacientes tienen dos o más manifestaciones cutáneas asociadas, que el Hospital Militar Central es un centro de atención nivel IV y de remisión nacional de pacientes de todas las Fuerzas Militares, se realizó el presente estudio con el fin de describir las patologías dermatológicas presentes en la población pediátrica relacionadas con la infección de VIH durante el 2006.
Biografía del autor/a
Dora Luz Fonseca Osorio
Residente de tercer año. Dermatología, Universidad Militar Nueva Granada, Bogotá.
Referencias bibliográficas
1. Molyneux E. Bacterial infections in children with HIV/AIDS. Trop Doct. 2004; 34: 195-8.
2. Raj R, Verghese A. Human immunodeficiency virus infections in adolescents. Adolesc Med. 2000; 11: 359-74.
3. Abrams EJ. Opportunistic infections and other clinical manifestations of HIV disease in children. Pediatr Clin North Am. 2000; 47: 79-108.
4. Spira R, Mignard M, Doutre MS, Morlat P, Dabis F. Prevalence of Cutaneous Disorders in a Population of HIV-Infected Patients: Southwestern France. Arch Dermatol. 1998; 134: 1208-12.
5. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing ungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50: 243-60.
6. Kamin D, Hadigan C. Hyperlipidemia in children with HIV infection: an emerging problem. Expert Rev Cardiovasc Ther. 2003; 1: 143-50.
7. Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Ribera E, et al. Prevention of opportunistic infections in adult and adolescent patients with HIV infection. Enferm Infecc Microbiol Clin. 2004; 22:271.
8. Alam M, Grossman ME, Longley BJ, Schneiderman PI. Kwashiorkor in Patients With AIDS. Cutis. 2001; 67: 321-4.
9. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004; 36 :11-9.
10. Schoeberlein DR, Belzer ME, Woolston JL. HIV prevention for teenage girls: relationships are the medium and the message. AIDS Read.1999; 9: 113-8, 121.
11. Balarezo FS, Joshi VV. Proliferative and neoplastic disorders in children with acquired immunodeficiency syndrome. Adv Anat Pathol. 2002; 9: 360-70.
12. Brown CW Jr, O'Donoghue M, Moore J, Tharp M. Recalcitrant Molluscum Contagiosum in an HIV-Afflicted Male Treated Successfully With Topical Imiquimod. Cutis. 2000;65: 363-6.
13. Mautner GH, Lu I, Ort RJ, Grossman ME. Transverse Leukonychia With Systemic Infection. Cutis. 2000; 65: 318-20.
14. Tóth FD, Bácsi A, Beck Z, Szabó J. Vertical transmission of human immunodeficiency virus. Acta Microbiol Immunol Hung. 2001; 48: 413-27.
15. Resnick S. Skin signs of sexually transmitted diseases in adolescents. Adolesc Med. 2001;12: 285-303.
16. Nielsen K, Bryson YJ. Diagnosis of HIV infection in children. Pediatr Clin North Am. 2000; 47: 39-63.
17. Luzuriaga K, Sullivan JL. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev. 2002; 4: 21-6.
18. Raoult D, Foucault C, Brouqui P. Infections in the homeless. Lancet Infect Dis. 2001; 1: 77-84.
19. Bryan MG, Elston DM, Hivnor C, Honl BA. Phaeohyphomycosis in a Premature Infant. Cutis. 2000; 65:137-140.
20. Blevins, JY. Primary Herpetic Gingivostomatitis In Young Children. Pediatr Nurs. 2003; 29: 199-202.
21. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis. 2004;10:13-8.
22. Singh A, Georgalas C, Patel N, Papesch M. Presentations in children with HIV infection. Clinical Otolaryngology & Allied Sciences. 2003; 28: 240-3.
23. Nikkels AF, Simonart T, Kentos A, Liesnard C, Sadzot-Delvaux C, Piérard GE, et al. Atypical recurrent varicella in 4 patients with hemopathies. J Am Acad Dermatol. 2003; 48: 442-7.
24. Oh TJ, Eber R, Wang HL. Periodontal diseases in the child and adolescent. Journal of Clinical Periodontology. 2002; 29: 400-10.
25. Hoang MT, Friedlander SF. Rare cutaneous malignancies of childhood. Curr Opin Pediatr. 1999; 11: 464-70.
26. Hoernle EH, Reid TE. Human immunodeficiency virus infection in children. American Journal of Health-System Pharmacy. 1995; 52: 961-79.
27. Samet JH, Muz P, Cabral P, Jhamb K, Suwanchinda A, Freedberg KA. Dermatologic Manifestations in HIV-Infected Patients: A Primary Care. Mayo Clin Proc. 1999;74:658-60.
28. Samet JH, Libman H, LaBelle C, Steger K, Lewis R, Craven DE, et al. A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med. 1995;155:1629-33.
29. El Hachem M, Bernardi S, Giraldi L, Diociaiuti A, Palma P, Castelli-Gattinara G. Herpetic whitlow as a harbinger of pediatric HIV-1 infection. Pediatr Dermatol. 2005; 22:119-21.
30. Wu JJ, Huang DB, Pang KR, Tyring SK.Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. J Am Acad Dermatol. 2004; 50: 495-528.
31. Martínez-Rojano H, Juárez Hernández E, Ladrón De Guevara G, del Carmen Gorbea-Robles M. Rheumatologic Manifestations of Pediatric HIV Infection. AIDS Patient Care STDS. 2001;15:519-26.
32. Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S, Reichart PA. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med. 2001;30:549-52.
33. Wananukul S, Thisyakorn U. Mucocutaneous Manifestations of HIV Infection in 91 Children Born to HIV-Seropositive Women. Pediatr Dermatol. 1999;16:359-63.
34. Prose NS. Skin manifestations of HIV-1 infection in children. Clin Dermatol.1991;9:59-64.
35. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004;22:487-98.
36. Yen-Moore A, Vander Straten M, Carrasco D, Evans TY, Tyring SK. Cutaneous viral infections in HIV-infected individuals. Clin Dermatol. 2000;18:423-32.
37. Cribier B, Mena ML, Rey D, Partisani M, Fabien V, Lang JM, et al. Nail Changes in Patients Infected With Human Immunodeficiency Virus: A Prospective Controlled Study. Arch Dermatol.1998;134:1216-20.
38. High WA, Evans CC, Hoang MP. Cutaneous miliary tuberculosis in two patients with hiv infection. J Am Acad Dermatol.2004; 50(5 Suppl):s110-3.
39. Zampogna JC, Flowers FP. Persistent verrucous varicella as the initial manifestation of HIV. J Am Acad Dermatol.2001;44(2 Suppl):391-4
40. Gregory N. Special patient populations: Onychomycosis in the HIV-positive patient. J Am Acad Dermatol.1996; 35 (3 Pt 2):S13-16
41. Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiretroviral therapy. J Am Acad Dermatol.2002;46:284-93.
42. Resolución No.00412 de 2000. Guía de Atención del VIH/SIDA. Ministerio de Protección Social. Colombia.
43. Murakawa GJ, Harvell JD, Lubitz P, Schnoll S, Lee S, Berger T. Cutaneous Aspergillosis and Acquired Immunodeficiency Syndrome. Arch Dermatol. 2000;136:365-9.
2. Raj R, Verghese A. Human immunodeficiency virus infections in adolescents. Adolesc Med. 2000; 11: 359-74.
3. Abrams EJ. Opportunistic infections and other clinical manifestations of HIV disease in children. Pediatr Clin North Am. 2000; 47: 79-108.
4. Spira R, Mignard M, Doutre MS, Morlat P, Dabis F. Prevalence of Cutaneous Disorders in a Population of HIV-Infected Patients: Southwestern France. Arch Dermatol. 1998; 134: 1208-12.
5. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing ungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002; 50: 243-60.
6. Kamin D, Hadigan C. Hyperlipidemia in children with HIV infection: an emerging problem. Expert Rev Cardiovasc Ther. 2003; 1: 143-50.
7. Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Ribera E, et al. Prevention of opportunistic infections in adult and adolescent patients with HIV infection. Enferm Infecc Microbiol Clin. 2004; 22:271.
8. Alam M, Grossman ME, Longley BJ, Schneiderman PI. Kwashiorkor in Patients With AIDS. Cutis. 2001; 67: 321-4.
9. Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health. 2004; 36 :11-9.
10. Schoeberlein DR, Belzer ME, Woolston JL. HIV prevention for teenage girls: relationships are the medium and the message. AIDS Read.1999; 9: 113-8, 121.
11. Balarezo FS, Joshi VV. Proliferative and neoplastic disorders in children with acquired immunodeficiency syndrome. Adv Anat Pathol. 2002; 9: 360-70.
12. Brown CW Jr, O'Donoghue M, Moore J, Tharp M. Recalcitrant Molluscum Contagiosum in an HIV-Afflicted Male Treated Successfully With Topical Imiquimod. Cutis. 2000;65: 363-6.
13. Mautner GH, Lu I, Ort RJ, Grossman ME. Transverse Leukonychia With Systemic Infection. Cutis. 2000; 65: 318-20.
14. Tóth FD, Bácsi A, Beck Z, Szabó J. Vertical transmission of human immunodeficiency virus. Acta Microbiol Immunol Hung. 2001; 48: 413-27.
15. Resnick S. Skin signs of sexually transmitted diseases in adolescents. Adolesc Med. 2001;12: 285-303.
16. Nielsen K, Bryson YJ. Diagnosis of HIV infection in children. Pediatr Clin North Am. 2000; 47: 39-63.
17. Luzuriaga K, Sullivan JL. Pediatric HIV-1 infection: advances and remaining challenges. AIDS Rev. 2002; 4: 21-6.
18. Raoult D, Foucault C, Brouqui P. Infections in the homeless. Lancet Infect Dis. 2001; 1: 77-84.
19. Bryan MG, Elston DM, Hivnor C, Honl BA. Phaeohyphomycosis in a Premature Infant. Cutis. 2000; 65:137-140.
20. Blevins, JY. Primary Herpetic Gingivostomatitis In Young Children. Pediatr Nurs. 2003; 29: 199-202.
21. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis. 2004;10:13-8.
22. Singh A, Georgalas C, Patel N, Papesch M. Presentations in children with HIV infection. Clinical Otolaryngology & Allied Sciences. 2003; 28: 240-3.
23. Nikkels AF, Simonart T, Kentos A, Liesnard C, Sadzot-Delvaux C, Piérard GE, et al. Atypical recurrent varicella in 4 patients with hemopathies. J Am Acad Dermatol. 2003; 48: 442-7.
24. Oh TJ, Eber R, Wang HL. Periodontal diseases in the child and adolescent. Journal of Clinical Periodontology. 2002; 29: 400-10.
25. Hoang MT, Friedlander SF. Rare cutaneous malignancies of childhood. Curr Opin Pediatr. 1999; 11: 464-70.
26. Hoernle EH, Reid TE. Human immunodeficiency virus infection in children. American Journal of Health-System Pharmacy. 1995; 52: 961-79.
27. Samet JH, Muz P, Cabral P, Jhamb K, Suwanchinda A, Freedberg KA. Dermatologic Manifestations in HIV-Infected Patients: A Primary Care. Mayo Clin Proc. 1999;74:658-60.
28. Samet JH, Libman H, LaBelle C, Steger K, Lewis R, Craven DE, et al. A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med. 1995;155:1629-33.
29. El Hachem M, Bernardi S, Giraldi L, Diociaiuti A, Palma P, Castelli-Gattinara G. Herpetic whitlow as a harbinger of pediatric HIV-1 infection. Pediatr Dermatol. 2005; 22:119-21.
30. Wu JJ, Huang DB, Pang KR, Tyring SK.Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. J Am Acad Dermatol. 2004; 50: 495-528.
31. Martínez-Rojano H, Juárez Hernández E, Ladrón De Guevara G, del Carmen Gorbea-Robles M. Rheumatologic Manifestations of Pediatric HIV Infection. AIDS Patient Care STDS. 2001;15:519-26.
32. Khongkunthian P, Grote M, Isaratanan W, Piyaworawong S, Reichart PA. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med. 2001;30:549-52.
33. Wananukul S, Thisyakorn U. Mucocutaneous Manifestations of HIV Infection in 91 Children Born to HIV-Seropositive Women. Pediatr Dermatol. 1999;16:359-63.
34. Prose NS. Skin manifestations of HIV-1 infection in children. Clin Dermatol.1991;9:59-64.
35. Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol. 2004;22:487-98.
36. Yen-Moore A, Vander Straten M, Carrasco D, Evans TY, Tyring SK. Cutaneous viral infections in HIV-infected individuals. Clin Dermatol. 2000;18:423-32.
37. Cribier B, Mena ML, Rey D, Partisani M, Fabien V, Lang JM, et al. Nail Changes in Patients Infected With Human Immunodeficiency Virus: A Prospective Controlled Study. Arch Dermatol.1998;134:1216-20.
38. High WA, Evans CC, Hoang MP. Cutaneous miliary tuberculosis in two patients with hiv infection. J Am Acad Dermatol.2004; 50(5 Suppl):s110-3.
39. Zampogna JC, Flowers FP. Persistent verrucous varicella as the initial manifestation of HIV. J Am Acad Dermatol.2001;44(2 Suppl):391-4
40. Gregory N. Special patient populations: Onychomycosis in the HIV-positive patient. J Am Acad Dermatol.1996; 35 (3 Pt 2):S13-16
41. Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiretroviral therapy. J Am Acad Dermatol.2002;46:284-93.
42. Resolución No.00412 de 2000. Guía de Atención del VIH/SIDA. Ministerio de Protección Social. Colombia.
43. Murakawa GJ, Harvell JD, Lubitz P, Schnoll S, Lee S, Berger T. Cutaneous Aspergillosis and Acquired Immunodeficiency Syndrome. Arch Dermatol. 2000;136:365-9.
Cómo citar
1.
Fonseca Osorio DL. Caracterización de la patología dermatológica presente en la población pediátrica infectada con el virus de inmunodeficiencia humana del Hospital Militar Central atendida durante el año 2006. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 6 de febrero de 2019 [citado 19 de abril de 2024];16(2):72-81. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/107
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2019-02-06
Cómo citar
1.
Fonseca Osorio DL. Caracterización de la patología dermatológica presente en la población pediátrica infectada con el virus de inmunodeficiencia humana del Hospital Militar Central atendida durante el año 2006. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 6 de febrero de 2019 [citado 19 de abril de 2024];16(2):72-81. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/107
Número
Sección
Artículo Original
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
